%PDF-1.3
%
3 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
6 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2020-01-20T23:22:26-08:00
2019-08-09T00:54:41+05:30
application/pdf
BIO-2019-0042-ver9-Baber_3P 372..374
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
uuid:d13499a6-3d35-4d07-bc48-a1f751ff5861
uuid:2485adff-da99-4d50-97fb-65e2cc3e6465
endstream
endobj
7 0 obj
<>stream
x+ |
endstream
endobj
8 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
9 0 obj
<>stream
x+ |
endstream
endobj
10 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
14 0 obj
<>stream
/GS1 gs
BT
/F1 1 Tf
9.9626 0 0 9.9626 59.7543 725.0455 Tm
0 0 0 rg
0 Tc
0 Tw
[(Intr)-8.8(oduction)]TJ
/F7 1 Tf
0 -1.7868 TD
[(Deni)-9.3(tion)-337.5(and)-335.7(mot)-7(ivation)-336.4(for)-336.3(co)-6.4(operation)]TJ
0 -1.2007 TD
[(with)-342.2(industry:)-339.5(bene)-6.4(ts)-334.3(and)-335.7(ch)-6.4(allenge)-7.7(s)]TJ
/F4 1 Tf
26.1167 0 0 26.1167 59.7543 666.5951 Tm
(C)Tj
/F8 1 Tf
9.843 0 0 9.843 78.1228 677.4235 Tm
[(ooperation)-404.5(with)-404.4(industry)]TJ
/F4 1 Tf
12.4352 0 TD
[(comprises)-404.8(both)-396.2(types)-404(of)]TJ
-12.4352 -1.1116 TD
[(projects)-454.7(in)-445.8(which)-451.2(\(1\))-452.5(academic)-453.7(biobanks)-453.4(provide)-446.7(the)]TJ
-1.8661 -1.1116 TD
[(pharmaceutical)-438.7(or)-428.4(diagnostics)-434.9(industry)]TJ
/F9 1 Tf
7.3823 0 0 6.5614 217.8141 659.9053 Tm
({)Tj
/F4 1 Tf
9.843 0 0 9.843 225.7511 655.54 Tm
[(with)-426(existi)-8(ng)-428.4(bio-)]TJ
-16.8644 -1.1174 TD
[(samples)-356.6(and)-355.8(related)-357(data)-352.4(under)-352.2(appropriate)-361.4(conditions,)-349.9(and)]TJ
0 -1.1116 TD
[(projects)-546.8(in)-549.5(which)-543.3(\(2\))-544.6(biobanks)-545.6(merely)-545.9(take)-548.3(care)-543.5(of)-543.6(the)]TJ
T*
[(sample)-488.2(logistics)-489.3(\(including)-490.6(storage\)for)-488.8(example,)-488.3(in)-486.1(the)]TJ
0 -1.1174 TD
[(frame)-285.5(of)-284.4(clinical)-283.5(trials.)-282.1(Although)-286.4(the)-281.1(rst)-280.6(of)-284.4(these)-278.5(options)-284.2(is)]TJ
0 -1.1116 TD
[(often)-340.8(viewed)-344(critically)-343.4(\(depending)-341.7(on)-342(the)-338.7(prevailing)-342(condi-)]TJ
T*
[(tions/framework\),)-325.1(the)-315.6(second)-319.8(one)-315.5(merely)-315.5(using)-316.5(the)-315.6(biobank)]TJ
T*
[(infrastructu)-9.9(re)-233.7(is)-238.3(not.)]TJ
/F10 1 Tf
7.3823 0 0 6.5614 139.2944 583.1998 Tm
({)Tj
/F4 1 Tf
9.843 0 0 9.843 145.3039 578.8345 Tm
[(This)-235.9(position)-239.4(article,)-239.6(therefore,)-241.5(focuses)]TJ
-8.6914 -1.1174 TD
[(exclusively)-326.8(on)-324.7(cooperation)-326.9(where)-325.5(academic)-327(biobanks)-326.7(make)]TJ
0 -1.1116 TD
[(existing)-436.4(biosamples)-440.7(and)-436.4(related)-437.6(data)-433.1(available)-441.2(to)-434.3(industry)]TJ
T*
(partners.)Tj
1.0137 -1.1174 TD
[(To)-510.3(develop)-511.3(recommendations)-513.3(for)-510.1(cooperation)-511.2(with)-506.6(in-)]TJ
-1.0137 -1.1116 TD
[(dustry)-334.8(in)-330.6(the)-327.1(latter)-337.6(sense,)-333.4(the)-327.1(potential)-335.3(benets)-332.4(but)-331.7(also)-328(the)]TJ
T*
[(risks)-454.5(of)-457.2(such)-454.6(cooperation)-453.6(must)-454.8(be)-452.6(analyzed.)-460.5(In)-451.4(principle,)]TJ
0 -1.1174 TD
[(cooperation)-309.6(with)-299.3(industry)-308.3(harbors)-302.4(considerable)-305.9(potential,)-304.2(as)]TJ
0 -1.1116 TD
[(both)-361.6(the)-361.7(development)-362.7(of)-359.3(therapeutics)-363.6(and)-361.6(the)-361.7(validation)-359.4(of)]TJ
T*
[(diagnostics)-290.9(strongly)-285.3(depend)-285.4(on)-284.4(human)-284.4(biosamples)-290.9(and)-280.9(data.)]TJ
0 -1.1174 TD
[(In)-336.2(the)-338.7(case)-341.8(of)-336.2(cooperation)-338.4(with)-339.6(industry,)-340.6(it)-336.5(is)-336.2(generally)-336.2(de-)]TJ
0 -1.1116 TD
[(sirable)-361.4(that)-351.4(a)-359.4(majority)-357.1(of)-353.5(results)-354.3(and)-355.8(data)-358.2(generated)-354.5(by)-353.5(the)]TJ
T*
[(industry)-412(partner\(s\))-416.3(are)-414.5(returned)-408.6(to)-411.3(the)-413.5(academic)-413.4(donor)-408.7(in-)]TJ
T*
[(stitutions)-247.4(to)-238.5(enrich)-245.2(the)-240.7(academic)-246.4(database)-243.8(for)-245.1(future)-238.2(research)]TJ
0 -1.1174 TD
[(projects.)-544.5(Thus,)-544.5(cooperation)-545.7(with)-541.2(industry)-544.5(would)-542.2(provide)]TJ
0 -1.1116 TD
[(benets)-251.7(to)-244.2(medical)-243.1(research)-249.3(and,)-249.8(in)-244.2(the)-240.7(long)-246.4(term,)-246.5(ultimately)]TJ
T*
[(also)-339.6(to)-330.6(the)-332.9(donors/patients.)]TJ
1.0137 -1.1174 TD
[(Academic)-441.9(biobanks)-436.1(may)-437.7(also)-437.5(benet)-435.1(signicantly)-441.9(from)]TJ
-1.0137 -1.1116 TD
[(cooperation)-338.4(with)-333.8(industry,)-334.8(as)]TJ
0 -1.6703 TD
[(\(1\))-504.3(joint)-334.2(publications)-338.4(may)-334(arise)-336(from)-333.9(common)-332.8(projects;)]TJ
0 -1.1116 TD
[(\(2\))-504.3(successful)-365.4(joint)-363(\(industry\))-368.1(projects)-362.5(enhance)-369.5(the)-361.7(reputa-)]TJ
1.6703 -1.1174 TD
[(tion)-333(and)-332.8(visibility)-339.9(of)-330.5(academic)-338.5(biobanks;)]TJ
-1.6703 -1.1116 TD
[(\(3\))-504.3(cooperation)-419(with)-420.2(industry)-423.5(represents)-417.4(an)-423.8(additional)-417(ex-)]TJ
1.6703 -1.1116 TD
[(ternal)-521.8(source)-521.3(of)-514.8(funding)-520.4(for)-515.8(biobanks)-522.5(and)-517.1(may)-518.3(thus)]TJ
T*
[(contribute)-336.2(to)-330.6(biobanks)-339.3(long-term)-335(sustainability;)-341.9(and)]TJ
-1.6703 -1.1174 TD
[(\(4\))-504.3(collaboration)-525.2(and)-522.8(exchange)-520.3(with)-523.9(industry)-521.5(may)-524.1(boost)]TJ
1.6703 -1.1116 TD
[(mutual)-331.8(knowledge)-341.6(and)-332.8(experience.)]TJ
-.6566 -1.6703 TD
[(At)-492.8(the)-494.2(same)-497.3(time,)-488.5(howev)-7.5(er,)-490.6(cooperation)-493.9(with)-495.1(industry)]TJ
-1.0137 -1.1116 TD
[(also)-241.6(entails)-246.4(certain)-247.6(risks)-241.4(and)-240.6(challenges)-246.1(that)-242(require)-240.5(different)]TJ
0 -1.1174 TD
[(solutions)-338.2(and)-332.8(a)-336.3(dened)-331.3(framework.)]TJ
/F1 1 Tf
9.9626 0 0 9.9626 59.7543 223.4834 Tm
[(Gene)-10.5(ral)-335.5(Arrang)-9.7(ements)-341.7(for)-335.3(Cooperat)-11.1(ion)]TJ
0 -1.2007 TD
[(with)-341.2(Industr)-9.9(y)]TJ
/F4 1 Tf
9.843 0 0 9.843 69.7323 193.6629 Tm
[(German)-840.4(Biobank)-839.4(Alliance)-843(\(GBA\))-837.6(biobanks)-839.3(agreed)]TJ
-1.0137 -1.1116 TD
[(unanimously)-296.8(that)-299.6(an)-291.3(unrestricted)-304.8(transfer)-293.2(of)-295.9(biosamples)-296.7(and)]TJ
T*
[(related)-466.4(data)-461.9(to)-463.1(industry)-463.9(is)-457.1(unacceptable.)-467.4(Any)-465(release)-461.5(and)]TJ
0 -1.1174 TD
[(transfer)-408.4(of)-399.6(biosamples)-400.3(and)-401.9(related)-408.8(data)-398.5(to)-399.7(third)-403.1(parties)-401.7(al-)]TJ
0 -1.1116 TD
[(ways)-403.7(require)-396(a)-399.7(written)-401.8(proposal)-395.8(with)-397.2(a)-399.7(project)-401.9(description)]TJ
T*
[(outlining)-246.6(the)-246.5(planned)-246.3(use)-240.4(of)-244.1(the)-246.5(requested)-249.5(biosamples)-244.8(and/or)]TJ
T*
[(data.)-344.4(This)-339.6(description)-337.1(also)-339.6(forms)-340.5(the)-338.7(basis)-340.5(for)-337.3(the)-338.7(approval)]TJ
25.5097 60.6727 TD
[(by)-388.1(an)-389.3(independent)-390.3(competent)-395(\(i.e.,)-389.2(in)-388.2(Germany,)-389.9(appointed)]TJ
0 -1.1174 TD
[(according)-526.1(to)-526.5(state)-532(legislation\))-528.6(medical)-531.1(ethics)-527.4(committee.)]TJ
0 -1.1116 TD
[(Moreover,)-378.3(almost)-383.4(all)-379.1(academic)-384.6(biobanks)-378.5(have)-381.1(a)-382.4()50.8(Use)-380.6(and)]TJ
T*
[(Access)-402.2(Committee)46.2()-392.7(\(UAC\))-399.9(that)-403.2(nally)-393.8(decides)-402.8(on)-393.9(the)-402(re-)]TJ
T*
[(lease)-337.2(and)-332.8(transfer)-339.3(of)-330.5(biosamples)-337(and/or)-336.2(data.)]TJ
1.0137 -1.1174 TD
[(The)-270.6(following)-270.3(scenarios)-278.1(for)-268.2(cooperation)-275(with)-270.5(industry)-273.8(are)]TJ
-1.0137 -1.1116 TD
[(conceivable)-352.3(under)-352.2(the)-350.2(aforementioned)-349.8(procedural)-354.4(and)-350(ethi-)]TJ
T*
[(cal)-334.1(framework:)]TJ
0 -1.6703 TD
[(Scenario)-490.3(1:)-486.1(The)-495.2(industry)-486.9(partner)-493.9(may)-489.5(get)-488.4(access)-488.9(to)-491.9(bio-)]TJ
.9907 -1.1174 TD
[(samples)-500.6(and)-494(related)-495.2(data)-496.4(within)-497.4(the)-494.2(scope)-497.2(of)-497.5(research)]TJ
0 -1.1116 TD
[(cooperation,)-318.8(ideally)-315.7(documented)-315.4(by)-307.5(a)-313.3(subsequent)-312.6(author-)]TJ
T*
[(ship)-396(in)-399.7(scientic)-399.3(publication.)-398.5(In)-399.6(addition,)-399.7(the)-396.2(respective)]TJ
0 -1.1174 TD
.0129 Tc
[(\()-5.4(a)-.9(d)-5.5(v).3(is)-5.3(in)-5.5(g\))-679.3(eth)-5.5(i).2(c)-6.6(s)-673.4(c)-6.6(o).3(mm)-6.7(itt)]TJ
11.4561 0 TD
.0154 Tc
[(ee)-678(must)-671.2(approve)-672.3(t)2.7(he)-672.3(c)-4.1(o)2.8(l-)]TJ
-11.4561 -1.1116 TD
.0127 Tc
[(l)-5.8(a)-1.1(b)-5.7(ora)-6.8(ti)-5.8(ve)-404.3(pr)-5.6(oj)-5.8(ec)-6.8(t)-397.5(a)-6.8(nd)-403.1(t)-5.8(h).1(e)-404.3(b).1(i)-5.8(o).1(b)-5.7(a)-1.1(nk)-403.1(U)-6.5(A)-.8(C)-404.1(m)-1.1(u)-5.7(s).3(t)-403.2(g)-5.7(iv)-5.7(e)-398.5(i)-5.8(ts)]TJ
T*
.0161 Tc
[(permi)3.4(s)-2.1(s)3.7(i)-2.4(o)3.5(n)-2.3(.)]TJ
-.9907 -1.1116 TD
0 Tc
[(Scenario)-426.9(2:)-417(Under)-428(certain)-426.1(conditions)-421.3(\(e.g.,)-423.7(no)-422.7(specic)-425.7(re-)]TJ
.9907 -1.1174 TD
[(search)-326.7(interest)-328.1(of)-318.9(the)-327.1(biobank)-320(or)-324.7(its)-325.9(hosting)-318.8(institution)-329.5(in)]TJ
0 -1.1116 TD
[(the)-309.9(given)-306.3(topic\),)-310.9(the)-304.1(industry)-308.4(partner)-309.6(may)-305.2(also)-310.8(get)-304.1(access)]TJ
T*
[(to)-411.3(biosamples)-411.9(and)-407.6(related)-408.8(data)-415.8(as)-406.3(a)-411.2(service)-408.5(without)-412.2(ex-)]TJ
0 -1.1174 TD
[(plicit)-503.6(research)-508.5(cooperation.)-503.1(However,)-504.8(this)-499.8(will)-506.8(equally)]TJ
0 -1.1116 TD
[(require)-563(a)-555.2(proposal/project)-562.8(description)-561.8(to)-555.3(be)-556.3(submitted)]TJ
T*
[(both)-269.5(to)-267.3(the)-269.5(advising)-269.2(ethics)-268.2(committee)-275.4(and)-263.6(the)-269.5(UAC)-271(of)-267.1(the)]TJ
0 -1.1174 TD
[(respective)-338.2(biobank.)]TJ
.023 -1.6703 TD
[(Industry)-567.4(ultimately)-579.7(aims)-571.2(at)-573.7(using)-569.9(biosamples)-573.1(and)-574.7(re-)]TJ
-1.0137 -1.1116 TD
[(lated)-296.1(data)-300.6(from)-299.3(academic)-298.2(biobanks)-303.7(to)-296.1(develop)-298.2(products)-297.9(that)]TJ
T*
[(are)-420.3(suitable)-420.3(for)-417.9(therapeutic)-426.1(and/or)-416.8(diagnostic)-422.5(applications.)]TJ
T*
[(Commercial)-576.9(companies)-579(generally)-572.3(rely)-575.9(on)-572.4(their)-577.1(products)]TJ
0 -1.1174 TD
[(often)-346.6(returning)-345.3(a)-347.8(handsome)-352(prot)-345.3(that)-345.7(can)-351.2(be)-343.2(reinvested)-354.4(in)]TJ
0 -1.1116 TD
[(new)-374(developments.)-378.6(The)-380(direct)-377.8(sharing)-377.4(of)-370.8(such)-379.8(prots)-375(with)]TJ
T*
[(the)-574.8(biobankdonors/patients)-582(is)-578.1(neither)-580.5(feasible)-576.8(nor)-579.2(does)]TJ
0 -1.1174 TD
[(make)-503.3(sense.)-506.2(However,)-504.8(academic)-511.3(biobanks)-499.5(can)-506.7(ask)-505.4(for)-498.6(a)]TJ
0 -1.1116 TD
[(compensation)-242.6(for)-233.6(their)-237.3(own)-240.3(expenses.)]TJ
/F11 1 Tf
7.3823 0 0 6.5614 459.6093 378.8219 Tm
(x)Tj
/F4 1 Tf
9.843 0 0 9.843 465.1652 374.4566 Tm
[(The)-236()50.8(broad)-243.9(consent)52.3()]TJ
-15.6779 -1.1116 TD
[(template)-313.4(developed)-313(by)-313.2(the)-309.9(permanent)-314.2(Working)-315.3(Party)-311.9(of)-313.2(the)]TJ
0 -1.1174 TD
[(German)-299(Medical)-306.1(Ethics)-297(Committees)-305(\(AK-EK\))-299.4(states:)-303.8()50.8(You)]TJ
0 -1.1116 TD
[(will)-449.2(not)-452.7(receive)-456(any)-453.7(remuneration)-455.9(for)-452.5(donating)-453.7(your)-453.6(bio-)]TJ
T*
[(materials)-458.3(and/or)-462.9(data)-456.1(for)-458.2(medical)-462(research)-456.7(purposes.)-462.2([)]TJ
/F12 1 Tf
22.9582 0 TD
(.)Tj
/F4 1 Tf
.9964 0 TD
(])Tj
-23.9546 -1.1116 TD
[(The)-518.3(biobank)-515.9(may)-518.3(charge)-516.9(a)-520.6(reasonable)-516.7(compensation)-524.9(for)]TJ
0 -1.1174 TD
[(providing)-597.6(biomaterials)-600(and/or)-595.4(data)-594.3(to)-595.6(users.)46.8()-594.3(However,)]TJ
0 -1.1116 TD
[(there)-376.5(is)-376.5(no)-370.8(clear)-377.7(denition)-379.9(of)-370.8(what)-381()50.8(reasonable)45.6()-375.4(compen-)]TJ
T*
[(sation)-336.1(means.)]TJ
1.0137 -1.1174 TD
[(The)-310.9(concept)-316.6(of)-313.2()50.8(reasonable)-321.9(compensation)44.3()-312.1(for)-314.3(expenses)]TJ
-1.0137 -1.1116 TD
[(remained)-497.4(ambiguous)-501.8(during)-496.3(the)-494.2(workshop.)-502.5(However,)-499(the)]TJ
T*
[(GBA)-559(biobanks)-562.8(agreed)-563(that)-558.8(this)-563.2(compensation)-559.4(should)-565.2(in)]TJ
0 -1.1174 TD
[(principle)-444.6(be)-441.1(conned)-441.9(by)-439.9(the)-442.3(real)-444.6(full)-442.4(costs,)-441.8(meaning)-443.4(that)]TJ
0 -1.1116 TD
[(such)-581.3(nancial)-582.6(compensation)-582.5(should)-582.5(not)-579.4(exceed)-587.2(the)-580.6(full)]TJ
T*
[(costs.)-240.2(Coverage)-243.7(of)-238.3(the)-240.7(full)-235(costs)-242.6(incurred)-241.6(by)-238.3(the)-240.7(biobank)-239.4(was)]TJ
0 -1.1174 TD
[(considered)-342.7(a)-342.1(suitable)-339.6(guideline)-340.9(for)-343.1(the)-338.7(concept)-345.4(of)-336.2()50.8(reason-)]TJ
0 -1.1116 TD
[(able)49.7()-375.4(compensation)-380.9(and)-373.1(is)-376.5(an)-372(argument)-381.1(against)-378.7(a)-370.9(possible)]TJ
T*
[(reproach)-496.1(of)-497.5(unfair)-497.4(competition.)-497.7(However,)-499(a)-491.8(pure)-495.1(sale)-502(of)]TJ
T*
[(voluntarily)-497.6(donated)-499.7(biomaterials)-502(and/or)-497.4(related)-501(data)-496.4(with)]TJ
0 -1.1174 TD
[(clear)-487.1(prot)-483.5(intentions)-484.8(was)-489(deemed)-489.4(ethically)-486.2(unallowable.)]TJ
0 -1.1116 TD
[(Services)-392.2(provided)-396(for)-389.1(external)-398.4(partners)-391.2(and)-396.1(revenues)-392.2(from)]TJ
T*
[(research)-289.7(cooperation)-286.5(with)-287.8(external)-283.2(partners)-287.5(\(not)-286.7(afliated)-290.1(to)]TJ
0 -1.1174 TD
[(a)-434.2(university/university)-440.6(hospital\))-443.2(are)-437.6(also)-437.5(subject)-436.3(to)-434.3(value-)]TJ
0 -1.1116 TD
[(added)-336.1(tax)-332.9(and)-332.8(institutional)-338.7(overhead.)]TJ
ET
q
1 i
59.754 109.984 m
298.885 109.984 l
298.885 45.581 l
59.754 45.581 l
W n
0 0 0 RG
1 J 1 j .227 w 10 M []0 d
q 1 0 0 1 59.754 109.984 cm 0 0 m
490.677 0 l
S
Q
Q
BT
/F9 1 Tf
6.5633 0 0 5.8334 68.7685 103.2945 Tm
({)Tj
/F4 1 Tf
8.7511 0 0 8.7511 72.0567 99.3826 Tm
[(Unless)-270.5(explicitly)-269.4(stated)-269.8(otherwise,)-269.8(in)-268.5(the)-268.5(present)-274.9(article)-268.7(the)-275(term)]TJ
-1.4058 -1.0236 TD
[()54.4(industry)59()-347.2(comprises)-352.8(both)-343.9(the)-346.2(pharmaceutical)-352.4(and)-347.5(the)-346.2(diagnostics)]TJ
T*
(industries.)Tj
/F10 1 Tf
6.5633 0 0 5.8334 68.7685 76.422 Tm
({)Tj
/F4 1 Tf
8.7511 0 0 8.7511 72.0567 72.5102 Tm
[(It)-260.6(is)-266.9(important)-268.1(to)-262(note)-267.3(that)-266.1(this)-263.3(type)-267.3(of)-268.3(cooperation)-265.3(could)-266.2(also)-265.7(be)]TJ
-1.4058 -1.0236 TD
[(viewed)-391.5(critically)-385.8(when)-387.5(storage)-385.1(space)-391.3(at)-386.3(biobanks)-384.2(runs)-381(short.)-387.7(This)]TJ
T*
[(challenge)-503.5(must)-501.8(then)-494.1(be)-504.2(addressed)-500.2(by)-496.5(a)-498.8(storage)-501.7(strategy)-499.2(for)-498.9(the)]TJ
0 -1.0301 TD
[(respective)-337.3(biobank.)]TJ
ET
q
1 i
310.847 92.069 m
549.921 92.069 l
549.921 45.581 l
310.847 45.581 l
W n
0 0 0 RG
1 J 1 j .227 w 10 M []0 d
q 1 0 0 1 310.847 92.069 cm 0 0 m
490.677 0 l
S
Q
Q
BT
/F11 1 Tf
6.5633 0 0 5.8334 319.8046 85.3795 Tm
(x)Tj
/F4 1 Tf
8.7511 0 0 8.7511 322.696 81.4677 Tm
[(From)-626.2(an)-627.2(ethical)-626.5(perspective,)-630.3(the)-624.8(question)-629.1(of)-624.6()54.4(reasonable)55.3()]TJ
-1.354 -1.0236 TD
[(compensation)-481.8(also)-486(raises)-488.3(the)-488.8(question)-486.6(of)-482.1(patient)-489.2(reimbursement.)]TJ
T*
[(This)-247.7(is)-247.5(not)-254.4(discussed)-244.9(here)-255.4(further,)-249.2(although,)-244.6(since)-252.8(at)-250.2(present)-249(patients)]TJ
T*
[(basically)-447.6(donate)-447.6(their)-444.9(samples)-453.7(and)-444.7(are)-450.9(not)-442.2(involved)-449.3(in)-443.4(the)-449.9(com-)]TJ
0 -1.0301 TD
[(mercial)-332.3(or)-333.1(patent)-336.2(use)-332.9(of)-333.1(their)-334.7(biosamples)-332.4(and)-334.6(related)-334.8(data.)]TJ
/F1 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(POSITION)-339.9(STATEMENT)]TJ
53.0113 0 TD
(373)Tj
ET
endstream
endobj
27 0 obj
<>stream
hތNAo:Q#
L)3!$*
..Kx_DcؘChܣpKs 1v|]mj7ow.J%<ҹ+$TWXI%-eiHb{Ep]s@9@uKP
AxPGprhFCC#4z`[6$3c!!Nl HhE|.GTH01W3%5Jj^²B[K\0';:%RLt.דۇ r~9}e~ ȏ$
endstream
endobj
29 0 obj
<>stream
hޤT{PTU9nfPwc<عLNÉb]qX"lʆhHX\@|bzXN5];t95;gJ *jl!-Őe0J401zϊzv\6"TF[C,/GJsfF#:gd0,R^j)KI6&J-id(,Fl[2n]d),ZM.Rd䕒ml-:J,ATln%+ʳ[Vlا^@a
5B:H*d 'T*YtWPf_Qc.ۚ1<3Pe#Neu\XqM0)M}Ѝ
0a^
fJ!|&N$,LYeBXA"d(V--YWbP6ձ|Ru6v;_ |zQ\눣~G-u&i,a1rzTH#oz4[7hu"7.nl{3/A<S (Ihօ2|"%'EA/4p2&.:0*Uq*Oa,+eQ+,"Ĝ`Vvԟ/ZTd`)q#]tݸM0(,d;ͣԍ+h>ۇA0wag9(IT%!N4W%?G&[Y`Xb6aQ-vzP]Z-P\ٓȏ;)'OJ=[ye?il@}gPY$3-cWGqpVR3a%8ƀ\ߚw}r*,e:M7P>6R
m[Ex2;c銕ԅ@o{`?݃rT+nIТ0p+]
qU*qgȼnb-P|wKVn5ޏ8Ɇlc5!nn Nto*ΠGbH̒s
8cs3?/gƓAv2xEF_a$H
dwY8#6:=4"
qwr~gZ&Tpxŕ}iE
pD<JprPSE2R㇚/Qc@a;b[wlV}"n6i8Ʉu;PŖ\
Fa'uOlvy[K^ϙvꚌ̾+gṄ\&
c%;DwպcT7JOHTAv [Kf: $A,ouAk\kq=aхs$|%(*p*iJƭÑhoeOʨPHF6N